Sustained Tocilizumab and Adjunctive HydroBox Therapy in Refractory Takayasu Arteritis: An 11-year Case Report

CHEN-YU LIAO, JENG-WEI LU, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, WUN-LONG JHENG, FENG-CHENG LIU

Open source

DOI
10.21873/invivo.14530
Published
2026-10-29
Container
In Vivo
Publisher
International Institute of Anticancer Research
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21873/invivo.14530,
  title = {Sustained Tocilizumab and Adjunctive HydroBox Therapy in Refractory Takayasu Arteritis: An 11-year Case Report},
  author = {CHEN-YU LIAO and JENG-WEI LU and YI-JUNG HO and SHAN-WEN LUI and TING-YU HSIEH and WUN-LONG JHENG and FENG-CHENG LIU},
  year = {2026},
  journal = {In Vivo},
  doi = {10.21873/invivo.14530},
  url = {https://doi.org/10.21873/invivo.14530}
}

RIS

TY  - JOUR
TI  - Sustained Tocilizumab and Adjunctive HydroBox Therapy in Refractory Takayasu Arteritis: An 11-year Case Report
AU  - CHEN-YU LIAO
AU  - JENG-WEI LU
AU  - YI-JUNG HO
AU  - SHAN-WEN LUI
AU  - TING-YU HSIEH
AU  - WUN-LONG JHENG
AU  - FENG-CHENG LIU
PY  - 2026
JO  - In Vivo
DO  - 10.21873/invivo.14530
UR  - https://doi.org/10.21873/invivo.14530
ER  - 

APA

LIAO, C., LU, J., HO, Y., LUI, S., HSIEH, T., JHENG, W., & LIU, F. (2026). Sustained Tocilizumab and Adjunctive HydroBox Therapy in Refractory Takayasu Arteritis: An 11-year Case Report. In Vivo. https://doi.org/10.21873/invivo.14530

Source records